Biopharmaceutical products on the market
Historically, biopharmaceuticals were produced from a biological source, such as tissues, organs or eggs. However since the late 1970s, they have been increasingly produced using cell technologies. By now, more than 370 individual biopharmaceutical have received marketing approval from in United States and/or European Union.
A list of approved biopharmaceuticals, including recombinant antibody-based, nucleic acid-based and genetically engineered cell-based products by end of July 2018 has been published here.